Biomerica (BMRA) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 9.33% |
| Nov 30, 2025 | 5.06% |
| Aug 31, 2025 | 14.90% |
| May 31, 2025 | -13.49% |
| Feb 28, 2025 | -6.27% |
| Nov 30, 2024 | -14.45% |
| Aug 31, 2024 | -21.02% |
| May 31, 2024 | -13.19% |
| Feb 29, 2024 | -23.04% |
| Nov 30, 2023 | -25.72% |
| Aug 31, 2023 | -19.68% |
| May 31, 2023 | -22.85% |
| Feb 28, 2023 | -38.02% |
| Nov 30, 2022 | -43.33% |
| Aug 31, 2022 | -58.48% |
| May 31, 2022 | -38.29% |
| Feb 28, 2022 | 19.71% |
| Nov 30, 2021 | -40.80% |
| Aug 31, 2021 | -94.27% |
| May 31, 2021 | -44.87% |
| Feb 28, 2021 | -52.26% |
| Nov 30, 2020 | -54.16% |
| Aug 31, 2020 | -86.87% |
| May 31, 2020 | -71.35% |
| Feb 29, 2020 | -45.11% |
| Nov 30, 2019 | -15.31% |
| Aug 31, 2019 | -18.18% |
| May 31, 2019 | -71.42% |
| Feb 28, 2019 | -83.51% |
| Nov 30, 2018 | -14.42% |
| Aug 31, 2018 | -21.92% |
| May 31, 2018 | -103.88% |
| Feb 28, 2018 | -41.80% |
| Nov 30, 2017 | -25.24% |
| Aug 31, 2017 | -21.63% |
| May 31, 2017 | -41.62% |
| Feb 28, 2017 | -28.25% |
| Nov 30, 2016 | -24.90% |
| Aug 31, 2016 | -19.83% |
| May 31, 2016 | -36.45% |
| Feb 29, 2016 | -40.84% |
| Nov 30, 2015 | -1.99% |